CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P0
Near historical low
vs 5Y Ago
-2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-139.47%
20245035.06%
202399.48%
2022-17.46%
2021-77.46%
202068.58%
2019-11.33%
2018-75.00%
201728.83%
2016-63.00%